Bavister, BD. Early history of in vitro fertilization. Reprod, 2002;124:181–196.Google Scholar

Clarke, GN. A.R.T. and history. Hum Reprod, 2006;21:1645–1650.CrossRefGoogle ScholarPubMed

Yanagimachi, R, Chang, MC. Fertilization of hamster eggs in vitro. Nature, 1963;200:281–282.CrossRefGoogle ScholarPubMed

Edwards, RG. Maturation in vitro of human ovarian oocytes. Lancet, 1965;2:926.Google Scholar

Steptoe, PC. Laparoscopy in Gynaecology. Edinburgh: E & S Livingstone, 1967.Google Scholar

Steptoe, PC. Laparoscopy and ovulation. Lancet, 1968;2:913.CrossRefGoogle ScholarPubMed

Edwards, RG, Bavister, BD, Steptoe, PC. Early stages of fertilization in vitro of human oocytes matured in vitro. Nature, 1969;221:632–635.Google Scholar

Bavister, BD, Edwards, RG, Steptoe, PC. Identification of the midpiece and tail of the spermatozoon during fertilization of human eggs in vitro. J Reprod Fert, 1969;20:169–170.CrossRefGoogle ScholarPubMed

Steptoe, PC, Edwards, RG. Laparoscopic recovery of pre-ovulatory oocytes after priming of ovaries with gonadotrophins. Lancet, 1970;1:683–689.CrossRefGoogle Scholar

Steptoe, PC, Edwards, RG. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet, 1976;1:880–882.Google Scholar

Steptoe, PC, Edwards, RG. Birth after the reimplantation of a human embryo. Lancet, 1978;2:366.CrossRefGoogle ScholarPubMed

Trounson, A, Leeton, J, Wood, J et al. Pregnancies in the human by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science, 1981;212:681–682.Google Scholar

Jones, HW, Jones, GS, Andrews, MC, et al. The program for in vitro fertilization at Norfolk. Fertil Steril, 1982;381:14–21.Google Scholar

Steptoe, PC, Edwards, RG. Observations on 767 clinical pregnancies and 500 live births after human in-vitro fertilization. Hum Reprod, 1986;1:89–94.Google Scholar

Trounson, A, Mohr, L. Human pregnancy following cryopreservation thawing and transfer of an eight-cell embryo. Nature, 1983;305:707–709.CrossRefGoogle ScholarPubMed

Trounson, A, Leeton, J, Besanko, M et al. Pregnancy established in an infertile patient following transfer of a donated embryo fertilized in vitro. Br Med J, 1983;286:835–838.Google Scholar

Utian, WF, Goldfarb, JM, Kiwi, R et al. Preliminary experience with in vitro fertilization-surrogate gestational pregnancy. Fertil Steril, 1989;52:633–638.Google Scholar

Lenz, S, Lauritsen, JG. Ultrasonically guided percutaneous aspiration of human follicles under local anaesthesia: a new method of collecting oocytes for in vitro fertilization. Fertil Steril, 1982;38:673–677.Google Scholar

Gleicher, N, Friberg, J, Fullan, N et al. Egg retrieval for in vitro fertilisation by sonographically controlled vaginal culdocentesis. Lancet, 1983;2:508–509.Google Scholar

Wikland, M, Hamberger, L, Enk, L. Transvesical and transvaginal approaches for aspiration of follicles by use of ultrasound. Ann NY Acad Sci, 1985;442:683–689.Google Scholar

Porter, RN, Smith, W, Craft, IL et al. Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins. Lancet, 1984;2:1284–1285.CrossRefGoogle Scholar

Frydman, R, Cornel, C, de Zeigler, D et al. Prevention of premature luteinising hormone and progesterone rise with a GnRH antagonist Nal-Glu in controlled ovarian hyperstimulation. Fertil Steril, 1991;56:921–927.CrossRefGoogle ScholarPubMed

Germond, M, Dessole, S, Senn, A et al. Successful in vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet, 1992;339:1170.CrossRefGoogle ScholarPubMed

Devroey, P, Mannaerts, B, Smitz, J et al. First established pregnancy and birth after ovarian stimulation with recombinant follicle stimulating hormone (Org 32489). Hum Reprod, 1993;8:863–865.Google Scholar

Laws-King, A, Trounsen, A, Sathananthan, H et al. Fertilization of human oocytes by microinjection of a single spermatozoon under the zona pellucida. Fertil Steril, 1987;48:637–642.Google Scholar

Palermo, G, Joris, H, Devroey, P, Van Steirteghem, A. Pregnancies after intracytoplasmic sperm injection of single spermatozoon into an oocyte. Lancet, 1992;2:17–18.Google Scholar

Handyside, AH, Kontogianni, EH, Hardy, K et al. Pregnancies from biopsied human pre-implantation embryos sexed by Y-specific DNA amplification. Nature, 1990;344:768–770.Google Scholar

Verlinsky, Y, Ginsberg, N, Lifchez, A et al. Analysis of the first polar body: preconception genetic diagnosis. Hum Reprod, 1990;5:826–829.Google Scholar

Cha, KY, Yoon, SH, Ko, JJ et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from non-stimulated cycle, their culture in vitro and their transfer according to the donor oocyte program. Fertil Steril, 1989. Abstract O-00: In Proceedings of Annual Meeting of the American Fertility Society.Google Scholar

Silber, SJ, Nagy, Z, Liu, J, Tournaye, H et al. The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod, 1995;10:2031–2043.CrossRefGoogle ScholarPubMed

Reijo, R, Lee, T-Y, Salo, P et al. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Gene, 1995;10:383–393.CrossRefGoogle ScholarPubMed

Picton, HM, Wyns, C, Anderson, RA et al. A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys. Hum Reprod, 2015;30:2463–2475.Google Scholar

Gosden, RG. Restoration of fertility in sterilized mice by transferring primordial ovarian follicles. Hum Reprod, 1990;5:499–504.CrossRefGoogle Scholar

Gosden, RG, Baird, DT, Wade, JC et al. Restoration of fertility in oophorectomized sheep by ovarian autographs stored at −196°C. Hum Reprod, 1994;9:597–603.CrossRefGoogle Scholar

Oktay, K, Economos, K, Kan, M et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. J Am Med Ass, 2001;286:1490–1493.Google Scholar

Donnez, J, Dolmans, M, Demylle, D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004;364:1405–1410.Google Scholar

Anderson, RA, Wallace, WHB, Telfer, EE et al. Ovarian tissue cryopreservation for fertility preservation: Clinical and research perspectives. Hum Reprod Open, 2017;1. https://doi.org/10.1093/hropen/hox001Google Scholar

Silber, SJ, Lenahan, KM, Levine, DJ et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med, 2005;353:58–63.CrossRefGoogle ScholarPubMed

Nyboe, Andersen A, Goossens, V, Bhattacharya, S et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE. Hum Reprod, 2009;24:1267–1287.Google Scholar

De Geyter, C, Calhaz-Jorge, C, Wyns, C et al. The European IVF monitoring consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod, 2018;1–16. Advance access: https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dey242/50Google Scholar

Code of Practice 9th Edition. Human Fertilisation and Embryology Authority, London 2018 (Draft: For publication October 1, 2018). www.hfea.june-2018-code-of-practice-9th-edition-draftGoogle Scholar

International Federation of Fertility Societies (IFFS). IFFS surveillance 2016. Global Reproductive Health Open, 2016;1:1–143.Google Scholar

Fauser, BC, Edwards, RG. The early days of IVF [editorial]. Hum Reprod Update, 2005;11:439–459.Google Scholar

Edwards, RG, Sharpe, DJ. Social values and research in human embryology. Nature, 1971;231:87–91.Google Scholar

Steptoe, PC, Edwards, RG. Birth after reimplantation of a human embryo. Lancet, 1978;2:366.CrossRefGoogle ScholarPubMed

Edwards, RG, Steptoe, PC. A Matter of Life. London: Hutchinson, 1980.Google Scholar

Jones, HW Jr. The ethics of in vitro fertilization – 1981. In Edwards RG, Purdy JM (eds.) Human Conception in Vitro. London: Academic Press. 351–357.Google Scholar

Jones, HW, Jones, GS, Andrews, MC et al. The programme for in vitro fertilization at Norfolk. Fertil Steril, 1982;38:14–21.Google Scholar

Wood, C, Trounson, AO. Historical perspectives of IVF. 2000. In Trounson AO, Gardner DK (eds.) Handbook of in Vitro Fertilization, 2nd edn.Google Scholar

Cohen, J, Trounson, A, Dawson, J et al. The early days of IVF outside the UK. Hum Rep Update, 2005;11:439–459.Google Scholar

Edwards, RG. Introduction: the beginnings of human in-vitro fertilization. In Gardner, DK. et al. (eds.) Textbook of Assisted Reproductive Techniques. Informa UK Ltd. 2009, 17–30.Google Scholar

Martinez, F et al. Update on fertility preservation from the Barcelona International Society for Fertility Preservation – ESHRE – ASRM 2015 expert meeting: Indications, results and future perspectives. Hum Reprod, 2017;32(9);1802–1811. https://doi.org/10.1093/humrep/dex2180Google Scholar

Brown, L. My Life as the World’s First Test-Tube Baby. Bristol: Bristol Books CIC, 2015.Google Scholar

Kovacs, G, Brinsden, PR, DeCherney, A. In-Vitro Fertilization: The Pioneers’ History. Cambridge: Cambridge University Press, 2018.Google Scholar

Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7(6):535–543.Google Scholar

Whitehead, E et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin’s disease. Cancer, 1983;52(6):988–993.Google Scholar

Himelstein-Braw, R, Peters, H, Faber, M. Morphological study of the ovaries of leukaemic children. Br J Cancer, 1978;38(1):82–87.CrossRefGoogle ScholarPubMed

Familiari, G et al. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin’s disease. Hum Reprod, 1993;8(12):2080–2087.Google Scholar

Sklar, CA et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst, 2006;98(13):890–896.Google Scholar

Chemaitilly, W et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab, 2006;91(5):1723–1728.Google Scholar

Nielsen, SN et al. A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod Biomed Online, 2013;27(2):192–200.Google Scholar

Charpentier, AM et al. Anti-Mullerian hormone screening to assess ovarian reserve among female survivors of childhood cancer. J Cancer Surviv, 2014;8(4):548–554.Google Scholar

Thomas-Teinturier, C et al. Ovarian reserve after treatment with alkylating agents during childhood. Hum Reprod, 2015;30(6):1437–1446.Google Scholar

Luke, B et al. Assisted reproductive technology use and outcomes among women with a history of cancer. Hum Reprod, 2016;31(1):183–189.Google Scholar

Meirow, D et al. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod, 1999;14(7):1903–1907.Google Scholar

Meirow, D et al. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol, 2010;53(4):727–739.Google Scholar

Fan, W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol, 1999;57(11):1215–1221.Google Scholar

Stumm, S et al. Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor. Oncology, 2004;66(2):101–111.Google Scholar

Roti Roti, EC et al. Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent. PLoS One, 2012;7(8):e42293.Google Scholar

Lopes, F et al. Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles. Mol Hum Reprod, 2014;20(10):948–959.Google Scholar

Kalich-Philosoph, L et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med, 2013;5(185):185ra62.Google Scholar

Chen, XY et al. Follicle loss and apoptosis in cyclophosphamide-treated mice: What’s the matter? Int J Mol Sci, 2016;17(6)836.Google Scholar

Ben-Aharon, I et al. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol, 2010;8:20.Google Scholar

Lopez, SG, Luderer, U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med, 2004;36(11):1366–1377.Google Scholar

Anderson, RA et al. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod, 2006;21(10):2583–2592.Google Scholar

Rosendahl, M et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril, 2010 June;94(1):156–66, epub March 31.Google Scholar

Kalich-Philosoph, L, Roness, H, Carmely, A et al. Cyclophosphamide triggers follicle activation causing ovarian reserve “burn out”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med, 2013;15(5):185.Google Scholar

Lande, Y et al. Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro. Reprod Biomed Online, 2017;34(1):104–114.Google Scholar

Chang, EM et al. Cisplatin induces overactivation of the dormant primordial follicle through PTEN/AKT/FOXO3a pathway which leads to loss of ovarian reserve in mice. PLoS One, 2015;10(12):e0144245.Google Scholar

Jang, H et al. Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res, 2016;60(3):336–347.Google Scholar

Durlinger, AL, Visser, JA, Themmen, AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction, 2002;124(5):601–609.Google Scholar

Adhikari, D, Liu, K. Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocr Rev, 2009;30(5):438–464.Google Scholar

Kawamura, K et al. Hippo signaling disruption an Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A, 2013;110(43):17474–17479.CrossRefGoogle ScholarPubMed

Li, J et al. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A, 2010;107(22):10280–10284.Google Scholar

McLaughlin, M et al. Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles. Mol Hum Reprod, 2014;20(8):736–744.CrossRefGoogle ScholarPubMed

Durlinger, AL et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology, 2002;143(3):1076–1084.CrossRefGoogle ScholarPubMed

Durlinger, AL et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology, 1999;140(12):5789–5796.Google Scholar

Marcello, MF et al. Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer, 1990;66(10):2099–2104.Google Scholar

Meirow, D et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007;22(6):1626–1633.Google Scholar

Nicosia, SV, Matus-Ridley, M, Meadows, AT. Gonadal effects of cancer therapy in girls. Cancer, 1985;55(10):2364–2372.Google Scholar

Soleimani, R, Heytens, E, Oktay, K. Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. PLoS One, 2011;6(4):e19475.Google Scholar

Ben-Aharon, I et al. Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity. Oncologist, 2012;17(11):1386–1393.CrossRefGoogle ScholarPubMed

Bar-Joseph, H et al. In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels. PLoS One, 2011;6(9):e23492.Google Scholar

Sanders, JE et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996;87:3045–3052.Google Scholar

Green, DM et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 2009;27(16):2677–2685.CrossRefGoogle ScholarPubMed

Mackie, EJ, Radford, M, Shalet, SM. Gonadal function following chemotherapy for childhood Hodgkin’s disease. Med Pediatr Oncol, 1996;27(2):74–78.Google Scholar

Behringer, K et al. Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol, 2005;23(30):7555–7564.Google Scholar

Brusamolino, E et al. Treatment of early-stage Hodgkin’s disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. Haematologica, 2000;85(10):1032–1039.Google Scholar

De Bruin, ML et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood, 2008;111(1):101–108.Google Scholar

Hodgson, DC et al. Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol, 2006;25:11–15.Google Scholar

Gershenson, DM. Management of ovarian germ cell tumors. J Clin Oncol, 2007;25(20):2938–2943.Google Scholar

Gershenson, DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol, 1988;6(2):270–275.Google Scholar

Park, MC et al. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus, 2004; 13(8):569–574.Google Scholar

Blumenfeld, Z et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod, 1996;11(8):1620–1626.Google Scholar

Blumenfeld, Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryo, oocytes, or ovaries. Oncologist, 2007;12(9):1044–1054.Google Scholar

Elgindy, EA et al. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol, 2013;121(1):78–86.Google Scholar

Gerber, B et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol, 2011;29(17):2334–2341.CrossRefGoogle ScholarPubMed

Munster, PN et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol, 2012;30(5):533–538.Google Scholar

Sverrisdottir, A et al. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat, 2009;117(3):561–567.Google Scholar

Del Mastro, L et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA, 2011;306(3):269–276.Google Scholar

Badawy, A et al. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril, 2009;91(3):694–697.Google Scholar

Moore, HC et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med, 2015;372(10):923–932.Google Scholar

Song, G, Gao, H, Yuan, Z. Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial. Med Oncol, 2013;30(3):667.Google Scholar

Gonfloni, S et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med, 2009;15(10):1179–1185.Google Scholar

Kerr, JB et al. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell, 2012 November 9;48(3):343–352.Google Scholar

Morgan, S et al. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS One, 2013;8(7):e70117.Google Scholar

Kim, SY et al. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network. Cell Death Differ, 2013;20(8):987–997.Google Scholar

Hancke, K et al. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril, 2007;87(1):172–177.Google Scholar

Li, F et al. Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death. Hum Reprod, 2014;29(1):107–113.Google Scholar

Zhou, L et al. Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K/Akt/mTOR signaling pathway in vivo. J Ovarian Res, 2017;10(1):56.Google Scholar

Goldman, KN et al. mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proc Natl Acad Sci U S A, 2017;114(12):3186–3191.Google Scholar

Sonigo, C et al. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J, 2018;33(1):1278–1287,fj201801089R.Google Scholar

Kano, M et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A, 2017;114(9):E1688–E1697.Google Scholar

Meirow, D, Dor, J. Epidemiology and infertility in cancer patients. In Tulandi, T, Gosden, R (eds.)Preservation of Fertility. Abingdon: Taylor and Francis. 2004, 21–38.Google Scholar

SEER. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence, Survival & Mortality, November 2017 ed. 2018.Google Scholar

Mertens, AC, Yong, J, Dietz, AC, et al. Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program. Cancer. 2015;121(7):1108–1117. DOI:10.1002/cncr.29170Google Scholar

Landier, W, Armenian, S, Bhatia, S. Late effects of childhood cancer and its treatment. Pediatr Clin North Am, 2015;62(1):275–300. DOI:10.1016/j.pcl.2014.09.017Google Scholar

Anderson, RA, Brewster, DH, Wood, R et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod, 2018;33(7):1281–1290. DOI:10.1093/humrep/dey216Google Scholar

Wallace, WH, Kelsey, TW, Anderson, RA. Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation. Fertil Steril, 2016;105(1):6–12. DOI:10.1016/j.fertnstert.2015.11.041Google Scholar

Gerstl, B, Sullivan, E, Chong, S et al. Reproductive outcomes after a childhood and adolescent young adult cancer diagnosis in female cancer survivors: a systematic review and meta-analysis. J Adolesc Young Adult Oncol, 2018. DOI:10.1089/jayao.2018.0036CrossRefGoogle Scholar

Depmann, M, Faddy, MJ, van der Schouw, YT et al. The relationship between variation in size of the primordial follicle pool and age at natural menopause. J Clin Endocrinol Metab, 2015;100(6):E845–E851. DOI:10.1210/jc.2015-1298Google Scholar

Kelsey, TW, Anderson, RA, Wright, P, Nelson, SM, Wallace, WH. Data-driven assessment of the human ovarian reserve. Mol Hum Reprod, 2012;18(2):79–87. DOI:10.1093/molehr/gar059Google Scholar

Wallace, WH, Kelsey, TW. Human ovarian reserve from conception to the menopause. PLoS One, 2010;5(1):e8772. DOI:10.1371/journal.pone.0008772Google Scholar

Johnson, J, Canning, J, Kaneko, T, Pru, JK, Tilly, JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature, 2004;428(6979):145–150. DOI:10.1038/nature02316CrossRefGoogle ScholarPubMed

Lee, HJ, Selesniemi, K, Niikura, Y et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J Clin Oncol, 2007;25(22):3198–3204. DOI:10.1200/JCO.2006.10.3028Google Scholar

Johnson, J, Skaznik-Wikiel, M, Lee, HJ et al. Setting the record straight on data supporting postnatal oogenesis in female mammals. Cell Cycle, 2005;4(11):1471–1477. DOI:10.4161/cc.4.11.2186Google Scholar

Zou, K, Yuan, Z, Yang, Z et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol, 2009;11(5):631–636. DOI:10.1038/ncb1869CrossRefGoogle ScholarPubMed

Hummitzsch, K, Anderson, RA, Wilhelm, D et al. Stem cells, progenitor cells, and lineage decisions in the ovary. Endocr Rev, 2015;36(1):65–91. DOI:10.1210/er.2014-1079Google Scholar

McLaughlin, M, Kelsey, TW, Wallace, WH, Anderson, RA, Telfer, EE. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary. Hum Reprod, 2017;32(1):165–174. DOI:10.1093/humrep/dew260Google Scholar

Jadoul, P, Dolmans, MM, Donnez, J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update. 2010;16(6):617–630. DOI:10.1093/humupd/dmq010Google Scholar

Gao, W, Liang, JX, Yan, Q. Exposure to radiation therapy is associated with female reproductive health among childhood cancer survivors: a meta-analysis study. J Assist Reprod Genet, 2015;32(8):1179–1186. DOI:10.1007/s10815-015-0490-6Google Scholar

Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7(6):535–543.Google Scholar

Chow, EJ, Stratton, KL, Leisenring, WM et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 2016;17(5):567–576. DOI:10.1016/S1470-2045(16)00086-3Google Scholar

Wallace, WH, Thomson, AB, Kelsey, TW. The radiosensitivity of the human oocyte. Hum Reprod, 2003;18(1):117–121.Google Scholar

Salooja, N, Szydlo, RM, Socie, G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet, 2001;358(9278):271–276.Google Scholar

Sanders, JE, Hawley, J, Levy, W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996;87(7):3045–3052.Google Scholar

Wallace, WH, Shalet, SM, Crowne, EC, Morris-Jones, PH, Gattamaneni, HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol), 1989;1(2):75–79.Google Scholar

Anderson, RA, Mitchell, RT, Kelsey, TW et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol, 2015;3(7):556–567. DOI:10.1016/S2213-8587(15)00039-XGoogle Scholar

Wallace, WH, Thomson, AB, Saran, F, Kelsey, TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys, 2005;62(3):738–744. DOI:10.1016/j.ijrobp.2004.11.038Google Scholar

Davies, HA, Didcock, E, Didi, M et al. Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr Suppl, 1995;411:45–50; discussion 1.Google Scholar

Bath, LE, Anderson, RA, Critchley, HO, Kelnar, CJ, Wallace, WH. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod, 2001;16(9):1838–1844.Google Scholar

Constine, LS, Woolf, PD, Cann, D et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med, 1993;328(2):87–94. DOI:10.1056/NEJM199301143280203Google Scholar

Merchant, TE, Rose, SR, Bosley, C et al. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol, 2011;29(36):4776–4780. DOI:10.1200/JCO.2011.37.9453Google Scholar

Green, DM, Nolan, VG, Kawashima, T et al. Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril, 2011;95(6):1922–1927, 7 e1. DOI:10.1016/j.fertnstert.2011.02.002Google Scholar

Green, DM, Kawashima, T, Stovall, M et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 2009;27(16):2677–2685. DOI:10.1200/JCO.2008.20.1541Google Scholar

Marci, R, Mallozzi, M, Di Benedetto, L et al. Radiations and female fertility. Reprod Biol Endocrinol, 2018;16(1):112. DOI:10.1186/s12958-018-0432-0Google Scholar

Bath, LE, Critchley, HO, Chambers, SE et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol, 1999;106(12):1265–1272.Google Scholar

Larsen, EC, Schmiegelow, K, Rechnitzer, C et al. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand, 2004;83(1):96–102.Google Scholar

Wo, JY, Viswanathan, AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys, 2009;73(5):1304–1312. DOI:10.1016/j.ijrobp.2008.12.016Google Scholar

Zheng, Y, Lei, Q, Jongejan, A et al. The influence of retinoic acid-induced differentiation on the radiation response of male germline stem cells. DNA Repair (Amst), 2018;70:55–66. DOI:10.1016/j.dnarep.2018.08.027CrossRefGoogle ScholarPubMed

Shalet, SM, Tsatsoulis, A, Whitehead, E, Read, G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol, 1989;120(1):161–165.CrossRefGoogle ScholarPubMed

Castillo, LA, Craft, AW, Kernahan, J, Evans, RG, Aynsley-Green, A. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol, 1990;18(3):185–189.Google Scholar

Grundy, RG, Leiper, AD, Stanhope, R, Chessells, JM. Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia. Arch Dis Child, 1997;76(3):190–196.Google Scholar

Leiper, AD, Stanhope, R, Lau, T et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol, 1987;67(4):419–426.Google Scholar

Choi, M, Hayes, JP, Mehta, MP et al. Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report. Tumori, 2013;99(2):e38–e42. DOI:10.1700/1283.14205Google Scholar

Jonska-Gmyrek, J, Peczkowski, P, Michalski, W, et al. Radiotherapy in testicular germ cell tumours – a literature review. Contemp Oncol (Pozn), 2017;21(3):203–208. DOI:10.5114/wo.2017.69592Google ScholarPubMed

Argyle, CE, Harper, JC, Davies, MC. Oocyte cryopreservation: where are we now? Hum Reprod Update, 2016;22:440–449.Google Scholar

Devroey, P, Van Steirteghem, A. A review of ten years experience of ICSI. Hum Reprod Update, 2004;10:19–28.Google Scholar

Ward, E, DeSantis, C, Robbins, A, Kohler, B, Jemal, A. Childhood and adolescent cancer statistics. CA Cancer J Clin, 2014;64:83–103.Google Scholar

Oeffinger, KC, Mertens, AC, Sklar, CA et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med, 2006;355:1572–1582.Google Scholar

van Dorp, W, Haupt, R, Anderson, RA et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol, 2018:JCO2017763441.Google Scholar

Peate, M, Meiser, B, Hickey, M, Friedlander, M. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat, 2009;116:215–223.Google Scholar

Shandley, LM, Spencer, JB, Fothergill, A et al. Impact of tamoxifen therapy on fertility in breast cancer survivors. Fertil Steril, 2017;107:243–252 e245.Google Scholar

Lambertini, M, Kroman, N, Ameye, L et al. Long-term safety of pregnancy following breast cancer according to estrogen receptor status. J Natl Cancer Inst, 2018;110:426–429.Google Scholar

Frobisher, C, Lancashire, ER, Winter, DL, Jenkinson, HC, Hawkins, MM. Long-term population-based marriage rates among adult survivors of childhood cancer in Britain. Int J Cancer, 2007;121:846–855.Google Scholar

Koch, SV, Kejs, AM, Engholm, G et al. Marriage and divorce among childhood cancer survivors. J Pediatr Hematol Oncol, 2011;33:500–505.Google Scholar

Ganz, PA, Rowland, JH, Desmond, K, Meyerowitz, BE, Wyatt, GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol, 1998;16:501–514.Google Scholar

Howard-Anderson, J, Ganz, PA, Bower, JE, Stanton, AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst, 2012;104:386–405.Google Scholar

Himelstein-Braw, R, Peters, H, Faber, M. Influence of irradiation and chemotherapy on the ovaries of children with abdominal tumours. Br J Cancer, 1977;36:269–275.Google Scholar

Chapman, RM, Sutcliffe, SB, Malpas, JS. Cytotoxic-induced ovarian failure in women with Hodgkin’s disease. I. Hormone function. JAMA, 1979;242:1877–1881.CrossRefGoogle ScholarPubMed

Morgan, S, Anderson, RA, Gourley, C, Wallace, WH, Spears, N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update, 2012;18:525–535.Google Scholar

Kalich-Philosoph, L, Roness, H, Carmely, A et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med, 2013;5:185ra162.Google Scholar

Meirow, D, Dor, J, Kaufman, B et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007;22:1626–1633.Google Scholar

Oktem, O, Oktay, K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer, 2007;110:2222–2229.Google Scholar

Roti Roti, EC, Leisman, SK, Abbott, DH, Salih, SM. Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent. PLoS One, 2012;7:e42293.Google Scholar

Anderson, RA, Remedios, R, Kirkwood, AA et al. Chemotherapy regimen, age and pretreatment ovarian reserve as determinants of ovarian function after response-adapted therapy in patients with Hodgkin lymphoma: a prospective cohort study. Lancet Oncol, 2018 October;19(10):1328–1337.Google Scholar

Meistrich, ML. Male gonadal toxicity. Pediatr Blood Cancer, 2009;53:261–266.Google Scholar

van Alphen, MM, van de Kant, HJ, de Rooij, DG. Repopulation of the seminiferous epithelium of the rhesus monkey after X irradiation. Radiat Res, 1988;113:487–500.Google Scholar

Poganitsch-Korhonen, M, Masliukaite, I, Nurmio, M et al. Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agents. Leukemia, 2017;31:1460–1463.Google Scholar

Stukenborg, JB, Alves-Lopes, JP, Kurek, M et al. Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy. Hum Reprod, 2018;33:1677–1683.Google Scholar

Green, DM, Liu, W, Kutteh, WH et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Lancet Oncol, 2014;15:1215–1223.Google Scholar

Loren, AW, Mangu, PB, Beck, LN et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol, 2013;31:2500–2510.Google Scholar

Mitchell, RT, Stukenborg, JB, Jahnukainen, K. Male hypogonadism due to cancer treatment. In Winters, SJ, Huhtaniemi, IT (eds.) Male Hypogonadism: Basic, Clinical, and Therapeutic Principles. Springer: Humana Press, 2017.Google Scholar

Marmor, D, Grob-Menendez, F, Duyck, F, Delafontaine, D. Very late return of spermatogenesis after chlorambucil therapy: case reports. Fertil Steril, 1992;58:845–846.Google Scholar

Imai, A, Ichigo, S, Matsunami, K, Takagi, H, Kawabata, I. Ovarian function following targeted anti-angiogenic therapy with bevacizumab. Mol Clin Oncol, 2017;6:807–810.Google Scholar

Wallace, WH, Thomson, AB, Saran, F, Kelsey, TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys, 2005;62:738–744.Google Scholar

Sanders, JE, Hawley, J, Levy, W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996;87:3045–3052.Google Scholar

Salooja, N, Szydlo, RM, Socie, G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet, 2001;358:271–276.Google Scholar

Signorello, LB, Cohen, SS, Bosetti, C et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst, 2006;98:1453–1461.Google Scholar

Reulen, RC, Bright, CJ, Winter, DL et al. Pregnancy and labor complications in female survivors of childhood cancer: the British childhood cancer survivor study. J Natl Cancer Inst, 2017;109. DOI:10.1093/jnci/djx1056Google Scholar

Bath, LE, Critchley, HOD, Chambers, SE et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Brit J Obstet Gynaecol, 1999;106:1265–1272.Google Scholar

Kelsey, TW, Ginbey, E, Chowdhury, MM et al. A validated normative model for human uterine volume from birth to age 40 years. PLoS One, 2016;11:e0157375.Google Scholar

Bath, LE, Anderson, RA, Critchley, HOD, Kelnar, CJH, Wallace, WHB. Hypothalamic–pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod, 2001;16:1838–1844.Google Scholar

Ogilvy-Stuart, AL, Shalet, SM. Effect of radiation on the human reproductive system. Environ Health Perspect, 1993;101(Suppl 2):109–116.Google Scholar

van Dorp, W, Mulder, RL, Kremer, LC et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the international late effects of childhood cancer guideline harmonization group in collaboration with the PanCareSurFup consortium. J Clin Oncol, 2016;34:3440–3450.Google Scholar

Green, DM, Kawashima, T, Stovall, M et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 2009;27:2677–2685.Google Scholar

Green, DM, Sklar, CA, Boice, JD, Jr. et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol, 2009;27:2374–2381.Google Scholar

Chow, EJ, Stratton, KL, Leisenring, WM et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 2016;17:567–576.Google Scholar

Barton, SE, Najita, JS, Ginsburg, ES et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol, 2013;14:873–881.Google Scholar

Letourneau, JM, Ebbel, EE, Katz, PP et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer, 2012;118:1933–1939.Google Scholar

Bramswig, JH, Riepenhausen, M, Schellong, G. Parenthood in adult female survivors treated for Hodgkin’s lymphoma during childhood and adolescence: a prospective, longitudinal study. Lancet Oncol, 2015;16:667–675.Google Scholar

Behringer, K, Breuer, K, Reineke, T et al. Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol, 2005;23:7555–7564.Google Scholar

Swerdlow, AJ, Cooke, R, Bates, A et al. Risk of premature menopause after treatment for Hodgkin’s lymphoma. J Natl Cancer Inst, 2014;106(pii):dju207.Google Scholar

Petrek, JA, Naughton, MJ, Case, LD et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol, 2006;24:1045–1051.Google Scholar

Bath, LE, Wallace, WH, Shaw, MP, Fitzpatrick, C, Anderson, RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod, 2003;18:2368–2374.Google Scholar

Jayasinghe, YL, Wallace, WHB, Anderson, RA. Ovarian function, fertility and reproductive lifespan in cancer patients. Expert Rev Endocrinol Metab, 2018;13:125–136.Google Scholar

Anderson, RA, Themmen, APN, Al Qahtani, A, Groome, NP, Cameron, DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reprod, 2006;21:2583–2592.Google Scholar

Chai, J, Howie, AF, Cameron, DA, Anderson, RA. A highly-sensitive anti-Mullerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer. Eur J Cancer, 2014;50:2367–2374.Google Scholar

Dezellus, A, Barriere, P, Campone, M et al. Prospective evaluation of serum anti-Mullerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. Eur J Cancer, 2017;79:72–80.Google Scholar

Su, HC, Haunschild, C, Chung, K et al. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients. Cancer, 2014;120:3691–3698.Google Scholar

Anderson, RA, Cameron, DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab, 2011;96:1336–1343.Google Scholar

Hagen, CP, Vestergaard, S, Juul, A et al. Low concentration of circulating antimullerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. Fertil Steril, 2012;98:1602–1608 e1602.Google Scholar

Steiner, AZ, Pritchard, D, Stanczyk, FZ et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA, 2017;318:1367–1376.Google Scholar

Anderson, RA, Brewster, DH, Wood, R et al. The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod, 2018;33:1281–1290.Google Scholar

van Beek, RD, Smit, M, van den Heuvel-Eibrink, MM et al. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin’s lymphoma with chemotherapy during childhood. Hum Reprod, 2007;22:3215–3222.Google Scholar

Green, DM, Zhu, L, Zhang, N et al. Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol, 2013;31:1324–1328.Google Scholar

Kelsey, TW, McConville, L, Edgar, AB et al. Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors. PLoS One, 2017;12:e0181377.Google Scholar

Wallace, WH, Smith, AG, Kelsey, TW, Edgar, AE, Anderson, RA Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol, 2014;15:1129–1136.Google Scholar

Jones, GL, Hughes, J, Mahmoodi, N et al. Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol. BMJ Open, 2017;7: e013219.Google Scholar

Peate, M, Meiser, B, Cheah, BC et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer, 2012;106:1053–1061.Google Scholar

Anderson, RA, Mitchell, RT, Kelsey, TW et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol, 2015;3:556–567.Google Scholar